Golimumab in unresponsive ulcerative colitis

Golimumab in unresponsive ulcerative colitis

Elisabeth Lippert, Martina Müller, Claudia Ott University Hospital Regensburg, Department of Internal Medicine I, Regensburg, Germany Abstract: Ulcerative colitis (UC) is a chronic inflammation mainly affecting the colon mucosa. It predominantly occurs in younger patients. Until recently,...

Full description

Bibliographic Details
Main Authors:	Lippert E, Müller M, Ott C
Format:	Article
Language:	English
Published:	Dove Medical Press 2014-05-01
Series:	Biologics : Targets & Therapy
Online Access:	http://www.dovepress.com/golimumab-in-unresponsive-ulcerative-colitis-a17024

Similar Items

Golimumab in the treatment of ulcerative colitis
by: Georgina Cunningham, et al.
Published: (2019-01-01)

Golimumab for the treatment of ulcerative colitis
by: Löwenberg M, et al.
Published: (2014-03-01)

Golimumab Therapy in Ulcerative Colitis
by: Won Moon
Published: (2016-02-01)

Initial experience with golimumab in clinical practice for ulcerative colitis
by: Luisa Castro-Laria, et al.

Golimumab pharmacokinetics in ulcerative colitis: a literature review
by: Ines Harzallah, et al.
Published: (2017-01-01)

Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
by: Sofia Lanz, et al.
Published: (2021-08-01)

Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis
by: Pugliese D, et al.
Published: (2016-02-01)

Treatment persistence and colectomy-free outcomes in patients with ulcerative colitis receiving golimumab or adalimumab: a UK experience
by: Sami Hoque, et al.
Published: (2020-11-01)

Infliximab, adalimumab, golimumab, vedolizumab and tofacitinib in moderate to severe ulcerative colitis: comparative cost-effectiveness study in Poland
by: Pawel Petryszyn, et al.
Published: (2020-08-01)

Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab
by: Fernando Magro, et al.
Published: (2019-08-01)

Cost-Effectiveness Analysis of 1-Year Treatment with Golimumab/Standard Care and Standard Care Alone for Ulcerative Colitis in Poland.
by: Ewa Stawowczyk, et al.
Published: (2016-01-01)

Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study
by: Vermeire S, et al.
Published: (2018-07-01)

Golimumab improves work productivity in patients suffering from moderate to severe ulcerative colitis: results of a prospective study over 24 months
by: Niels Teich, et al.
Published: (2021-04-01)

Golimumab for Rheumatoid Arthritis
by: Eleftherios Pelechas, et al.
Published: (2019-03-01)

Golimumab for the treatment of psoriatic arthritis
by: H Yang, et al.
Published: (2011-05-01)

The abilities of golimumab in the therapy of ankylosing spondylitis
by: Sh. F. Erdes
Published: (2014-09-01)

GOLIMUMAB SAFETY ACCORDING TO CLINICAL FINDINGS
by: G. V. Lukina, et al.
Published: (2015-04-01)

Golimumab in the treatment of psoriatic arthritis: efficacy and safety
by: Tatiana Viktorovna Korotaeva, et al.
Published: (2015-09-01)

THE EFFECT OF GOLIMUMAB ON ARTERIAL STIFFNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: L. A. Knyazeva, et al.
Published: (2018-03-01)

Ulcerative colitis in infancy
by: Md Rukunuzzaman, et al.
Published: (2011-01-01)

Golimumab in the treatment of inflammatory diseases: A role of immunogenicity
by: D. E. Karateev
Published: (2016-01-01)

Safety and clinical efficacy of golimumab in the treatment of arthritides
by: Ismail Simsek, et al.
Published: (2010-09-01)

Unusual Manifestation of Ulcerative Colitis
by: Amna Basheer M. Ahmed, et al.
Published: (2019-01-01)

Ulcerative colitis or Crohn’s disease?
by: R. G. Artamonov, et al.
Published: (2016-03-01)

Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model
by: Rachel Archer, et al.
Published: (2016-05-01)

Infliximab in ulcerative colitis
by: Avi Levin, et al.
Published: (2008-09-01)

Dysplasia in Ulcerative Colitis
by: RH Riddell
Published: (1990-01-01)

ULCERATIVE COLITIS IN CHILDREN
by: Florea Iordăchescu
Published: (2009-03-01)

Mitochondria in Ulcerative Colitis
by: Eduard F. Stange, MD
Published: (2021-01-01)

Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry
by: Proton Rahman, et al.
Published: (2020-09-01)

The pathology of ulcerative colitis
by: Goodliffe, J. H.
Published: (1897)

Colitis ulcerativa idiopática Idiopathic ulcerative colitis
by: Alejandro García Gutiérrez
Published: (2007-12-01)

COMORBIDITIES IN PATIENTS WITH ULCERATIVE COLITIS
by: T. E. Chernyshova, et al.
Published: (2020-11-01)

Ulcerative Colitis from Genetics to Complications
Published: (2012)

Ulcerative Colitis Epidemiology, Pathogenesis and Complications
Published: (2011)

Peculiar Presentation of Ulcerative Colitis
by: Hamdy M. A. Ahmed, et al.
Published: (2016-01-01)

Ulcerative Colitis: Shifting Sands
by: Geert R. A. M. D’Haens, et al.
Published: (2019-03-01)

Uncovering the cause of ulcerative colitis
by: Ian C Roberts‐Thomson, et al.
Published: (2019-08-01)

MESALAZINE PLACE IN THERAPY OF ULCERATIVE COLITIS
by: I. G. Bakulin, et al.
Published: (2017-11-01)

Infliximab for the treatment of ulcerative colitis
by: C Hyde, et al.
Published: (2009-10-01)

Cannot write session to /tmp/vufind_sessions/sess_09g65padq6lbnev716rimoo69e